Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Loxoprofen Pain

Small molecule · Inhibitor of cyclooxygenase

Phase 2 Most advanced trial (none active)
1 Registered trials

What is Loxoprofen Pain?

Loxoprofen Pain Patch is a nonsteroidal anti-inflammatory drug (NSAID) formulated as a transdermal patch applied once daily. It is studied for the treatment of delayed onset muscle soreness.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Targets
cyclooxygenase
Mechanism
Inhibitor of cyclooxygenase
Therapy area
Musculoskeletal
In trials of
CAH
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02602353 Phase 2 Delayed Onset Muscle Soreness Completed CAH

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Delayed Onset Muscle Soreness

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.